| ANI Pharmaceuticals is a bio-pharmaceutical company focused on developing, manufacturing, and marketing branded and generic prescription pharmaceuticals. Co.'s products include: Candesartan Hydrochlorothiazide, Fenofibrate, Fluvoxamine, Hydrocortisone Enema, Lithium Carbonate ER, Mesalamine, Propranolol ER, Terbutaline, and Vancomycin. We show 43 historical shares outstanding datapoints in our ANIP shares outstanding history coverage, used to compute ANIP market cap on those dates.|
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing ANIP market cap history over the course of time is important for investors
interested in comparing ANIP's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of ANIP versus a peer is one thing; comparing
ANIP market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like ANIP can fluctuate over the course of history.
With this page we aim to empower investors researching ANIP by allowing them to research the ANIP market cap history.